Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q4 FY19 results · Jan–Mar 2019
Alkem Laboratories reported revenue from operations of ₹1,854.20 crore and net profit of ₹170.50 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,854.20 | — | — | 1,925.03 | −3.7% |
| Other income | 27.66 | — | — | 9.35 | +195.8% |
| Total income | 1,881.86 | — | — | 1,934.38 | −2.7% |
| Profit before tax | 198.81 | — | — | 258.06 | −23.0% |
| Net profit for the period | 170.50 | — | — | 205.45 | −17.0% |
| Attributable to shareholders of the company | 167.36 | — | — | 202.53 | −17.4% |
| EPS, basic (₹) | 14.00 | — | — | 16.94 | −17.4% |
| Net margin (%) | 9.2 | — | 10.7 |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,467.84 | — | — | 1,536.03 | −4.4% |
| Other income | 19.07 | — | — | 5.75 | +231.7% |
| Total income | 1,486.91 | — | — | 1,541.78 | −3.6% |
| Profit before tax | 214.65 | — | — | 286.92 | −25.2% |
| Net profit for the period | 190.82 | — | — | 241.23 | −20.9% |
| EPS, basic (₹) | 15.96 | — | — | 20.18 | −20.9% |
| Net margin (%) | 13.0 | — | 15.7 |
Consolidated
- Filed with BSE
- 30 May 2019, 20:39 IST
- Board meeting
- 30 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 May 2019, 20:39 IST
- Board meeting
- 30 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE